CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Clinical Trials
Original article

MRX1 Successfully Delivered to Clinical Trial Site

Trial StartMRX1Positive
AI Analysis

Summary

Ananda Pharma Limited announced successful delivery of MRX1, an investigational cannabidiol product, to a clinical trial site. The investigational product was manufactured in 2025.

Clinical Trial Data

Importance:2/10
Sentiment:
0.30
cannabidiolclinical trialmanufacturingUK-based

Read the original article

Published by PR Newswire Clinical Trials on July 6, 2026 7:00 AM

Read Original